Approximately 1.5 million patients worldwide have had metal-on-metal (MOM) arthroplasties implanted since 1996.1 Unfortunately, they have high failure rates due to adverse tissue reactions in the periprosthetic tissues.2,3 Ultrasound can detect these problems4–6 and, therefore, has been recommended by health regulatory guidelines7 on the clinical management of MOM hips.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: